People with diabetes undergoing haemodialysis Nutritional, Metabolic, Endocrine
Conditions
Interventions
Participants wear two different on-market glucose sensors concurrently for up to 10 days.
Participants perform four daily fingerprick blood glucose measurements using the provided blood glucose meter
Sponsors
Abbott Diabetes Care Ltd
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or over 2. Type 1 or type 2 diabetes, requiring insulin therapy 3. Willing and able to test their blood glucose levels via fingerprick at least four times a day using the provided system 3. On stable haemodialysis (i.e., treatment using dialysis has been in progress for a minimum of 90 days)
Exclusion criteria
Exclusion criteria: 1. Concomitant disease or condition that may compromise patient safety 2. Currently prescribed oral steroid therapy for any acute or chronic condition 3. Female participant known to be pregnant 4. Have a pacemaker or any other neurostimulators 5. Known (or suspected) allergy to medical-grade adhesives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consensus Error Grid (CEG) analysis measured using sensor glucose measurements assessed against capillary blood glucose (fingerprick) reference values and plotted onto CEG at during the sensor wear period (up to 10 days) across all paired measurements | — |
Countries
England, United Kingdom
Contacts
Public ContactPamela Reid
Outcome results
None listed